Skip to main content
VVT MED INC. logo

VVT MED INC. — Investor Relations & Filings

Ticker · VVTM ISIN · CA91841T1084 TSXV Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2021-03-01 Management Reports
Country CA Canada
Listing TSXV VVTM

About VVT MED INC.

https://www.vvtmed.com/

VVT MED INC. develops, manufactures, and commercializes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of varicose veins and chronic venous disorders. The company's technology centers on the ScleroSafe Platform, a patented delivery system for Endovenous Chemical Ablation (ECA). ScleroSafe is designed to simplify procedures, shorten treatment times, and minimize patient recovery compared to traditional surgical and ablation methods. Products like ScleroSafe and V-Block, which treats severely dilated Great Saphenous Vein conditions, offer enhanced safety and efficacy. The platform holds regulatory clearances including FDA 510(k) and CE approval.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management's Discussion and Analysis' (MD&A) for the year ended December 31, 2020, dated February 25, 2021. It contains detailed explanations of the company's financial results, operations, liquidity, capital resources, critical accounting estimates, and forward-looking statements. The text includes substantive financial data and analysis, such as net income figures, changes in working capital, and discussion of financing arrangements. It is not a brief announcement or a certification letter, nor is it a transcript or presentation. The presence of detailed management commentary and financial analysis aligns with the definition of a Management Reports (MDA) filing. Therefore, the document should be classified as MDA with high confidence.
2021-03-01 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'INDEPENDENT AUDITOR’S REPORT' and contains an auditor's opinion on the consolidated financial statements of DXI Capital Corp. for the years ended December 31, 2020 and 2019. It includes detailed financial statements such as the consolidated statements of financial position, comprehensive loss, changes in shareholders' equity, and cash flows. The report discusses the audit basis, responsibilities, and includes an auditor's opinion on the financial statements prepared under IFRS. The presence of detailed financial data and the auditor's report indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains the full audit opinion and financial statements, not just an announcement or certification. Therefore, the appropriate classification is 'Audit Report / Information' (AR). FY 2020
2021-03-01 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 Management Certification submitted to the Alberta Securities Commission. It includes certification by an officer (CEO) regarding the completeness and accuracy of information related to reporting issuer status, market values, and participation fees. The content is primarily a certification and fee calculation rather than a full financial report or detailed management discussion. It does not contain comprehensive financial statements or substantive financial analysis. Therefore, it fits the criteria of a Regulatory Filing (RNS) as it is a regulatory compliance document and officer certification rather than a full report or announcement.
2021-03-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS - PARTICIPATION FEE' and contains a 'MANAGEMENT CERTIFICATION' section signed by an officer certifying the accuracy of the information submitted to the Ontario Securities Commission. The content includes detailed market value calculations for specified trading periods and references OSC Rule 13-502 Fees. The document is a certification related to regulatory fee reporting rather than a financial report or management discussion. It is primarily an officer certification submitted to a regulatory body, which aligns with the definition of Regulatory Filings (RNS) as per the certification rule. The document length is 15,000 characters, but the content is a certification form, not a full financial or management report.
2021-03-01 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new COO/CFO and the engagement of a consulting group to assist in securing a strategic alternative business interest. It contains no financial statements, no detailed financial data, no regulatory form references, and no mention of shareholder votes or meetings. The content focuses on management changes and strategic business direction. The document length is 3935 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in senior management.
2020-12-07 English
Notice of ceasing to engage in oil and gas activities (form 51-101F5).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Notice of Ceasing to Engage in Oil and Gas Activities' and references Form 51-101F5, which is a regulatory form related to oil and gas disclosures. The content is a formal notice signed by the CEO, CFO, and directors, indicating a change in the company's business activities. The document is short (551 characters) and serves as an official announcement rather than a detailed report or financial statement. It does not contain financial data, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.